Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

Click on country-registry for comparison

Flag	Country Registry	Registration period	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
				Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
				No.	%	No.	%	<1	1-3	3-5	>5
	China - Shangai	1992-1995	639	634	99.2	5	0.8	0.2	0.2	0.2	0.2	99.4	25.9
	India - Karunagappally	1991-1997	32	29	90.6	3	9.4	6.3	3.1	0.0	0.0	90.6	34.0
	India - Mumbai	1992-1994	1463	1194	81.6	269	18.4	13.4	0.1	0.2	4.7	86.3	13.2
	Thailand - Chiang Mai	1993-1997	107	82	76.6	25	23.4	5.6	5.6	7.5	4.7	81.3	27.2
	Thailand - Lampang	1990-2000	171	170	99.4	1	0.6	0.0	0.0	0.0	0.6	100.0	49.6
	Thailand - Songkhla	1990-1999	144	91	63.2	53	36.8	11.8	10.4	5.6	9.0	72.2	24.9
	Uganda - Kampala	1993-1997	154	119	77.3	35	22.7	16.2	3.9	2.6	0.0	77.3	26.2
	Zimbabwe - Harare	1993-1997	64	61	95.3	3	4.7	4.7	0.0	0.0	0.0	95.3	16.6

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period